Literature DB >> 6581856

Genetic predisposition to breast cancer.

H T Lynch, W A Albano, B S Danes, M A Layton, W J Kimberling, J F Lynch, S C Cheng, K A Costello, G M Mulcahy, C A Wagner.   

Abstract

Breast cancer risk factors are closely intertwined with the patient's cultural background, which may contribute to breast cancer aggregations within families. The difficult questions are: (1) does a truly hereditary breast cancer subset exist; (2) which familial aggregations are hereditary; and (3) is the hereditary form distinctive from its sporadic counterpart? These queries will be resolved once biomarkers are identified that show high sensitivity and specificity with genotype. The authors provide a review of this subject and will focus on their recent discovery of increased in vitro hyperdiploidy in cultured skin fibroblasts from patients with or at risk for hereditary breast cancer. The authors discuss findings from their study of family histories in 225 consecutively ascertained patients with verified breast cancer from the Creighton University School of Medicine Oncology Clinic. Findings consistent with an hereditary breast cancer syndrome were identified in 5% of the patients. Given the 112,000 new cases of breast cancer in the United States in 1982, the authors estimate that with a confidence coefficient of 0.95 between 2410 and 8790 of these individuals will manifest hereditary breast cancer. Specific surveillance/management programs should be geared to high-risk members of these families in which cancer yield will be predictable.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6581856     DOI: 10.1002/1097-0142(19840201)53:3+<612::aid-cncr2820531306>3.0.co;2-5

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  19 in total

1.  Familial and histological analyses of 138 breast cancer patients.

Authors:  N Bürki; A Gencik; J K Torhorst; W Weber; H Müller
Journal:  Breast Cancer Res Treat       Date:  1987-11       Impact factor: 4.872

Review 2.  Familial breast cancer.

Authors:  R F Phipps; P M Perry
Journal:  Postgrad Med J       Date:  1988-11       Impact factor: 2.401

3.  Selective killing of preneoplastic and neoplastic cells by methotrexate with leucovorin.

Authors:  M Chow; H Rubin
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-14       Impact factor: 11.205

4.  Patient preferences and National Health Service costs: a cost-consequences analysis of cancer genetic services.

Authors:  Gethin L Griffith; Rhiannon Tudor Edwards; J Mark G Williams; Jonathon Gray; Val Morrison; Clare Wilkinson; Jim Turner; Barbara France; Paul Bennett
Journal:  Fam Cancer       Date:  2008-09-27       Impact factor: 2.375

5.  First application of next-generation sequencing in Moroccan breast/ovarian cancer families and report of a novel frameshift mutation of the BRCA1 gene.

Authors:  Farah Jouali; Fatima-Zahra Laarabi; Nabila Marchoudi; Ilham Ratbi; Siham Chafai Elalaoui; Houria Rhaissi; Jamal Fekkak; Abdelaziz Sefiani
Journal:  Oncol Lett       Date:  2016-06-16       Impact factor: 2.967

6.  Family history in ovarian cancer referral population.

Authors:  L A Berg; S Robert Young; K A Brooks; A M Davis; S Terry Smith
Journal:  J Genet Couns       Date:  1996-03       Impact factor: 2.537

7.  Redefined indications for subcutaneous mastectomy in patients with benign breast disease.

Authors:  V R Pennisi
Journal:  Aesthetic Plast Surg       Date:  1986       Impact factor: 2.326

8.  [Familial cancer. Initial results of an inquiry into its occurrence in Basel].

Authors:  H Müller; N Bürki; A Gencik; A Gencikova; E Kovacs; M Roth; N Trächslin; B Voegtli; W Weber
Journal:  Soz Praventivmed       Date:  1985

9.  Prevalence of aneuploidy, overexpressed ER, and overexpressed EGFR in random breast aspirates of women at high and low risk for breast cancer.

Authors:  C J Fabian; C Zalles; S Kamel; B F Kimler; R McKittrick; A S Tranin; S Zeiger; W P Moore; R S Hassanein; C Simon
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

10.  Oestrogen receptor (ESR) polymorphisms and breast cancer susceptibility.

Authors:  T I Andersen; K R Heimdal; M Skrede; K Tveit; K Berg; A L Børresen
Journal:  Hum Genet       Date:  1994-12       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.